Article Information
History
- August 14, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Omar Valenzuela, M.D.1,9,
- Sebastián Ibáñez, M.D.1,9,*,
- María Poli, M.D.2,9,
- Patricia Roessler, M.D.3,9,
- Mabel Aylwin, M.D.4,9,
- Gigia Roizen, M.D.3,9,
- Mirentxu Iruretagoyena, M.D.5,9,
- Vivianne Agar, M.D.6,9,
- Javiera Donoso, M.D.7,9,
- Margarita Fierro, T.N.3,9 and
- José Montes, M.D.8,9
- 1Rheumatology department, Clínica Alemana de Santiago, Chile.
- 2Pediatrics department, Clínica Alemana de Santiago, Chile.
- 3Immunology department, Clínica Alemana de Santiago, Chile.
- 4Infectology department, Clínica Alemana de Santiago, Chile.
- 5Clinical Laboratory, Clínica Alemana de Santiago, Chile.
- 6Respiratory Diseases department, Clínica Alemana de Santiago, Chile.
- 7Hematology department, Clínica Alemana de Santiago, Chile.
- 8Critical Patient Unit, Clínica Alemana de Santiago, Chile.
- 9Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
- ↵*Corresponding author:
Sebastián Ibáñez, Clínica Alemana de Santiago, Av. Manquehue Norte 1410, piso 7, Vitacura, 7650567, Santiago, Chile., Phone: 56991382557, E-mail address: sibanez{at}alemana.cl
Posted August 14, 2020.
First report of tocilizumab use in a cohort of Latin American patients hospitalized for severe COVID-19 pneumonia
